Skip to main content

PAVmed Inc.

PAVM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001624326

No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding PAVmed Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of PAVM: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders5865+7
Shares9.27M12.5M+3.19M (+34.3%)
Value$3.78M$3.67M−$112.8K (−3.0%)

New holders (11)

Institutions that held PAVmed Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PAVM in Q3 2023
InstitutionSharesValue% of portfolio
First Manhattan Co1,000,000$294.6K0.00%
Two Sigma Securities, LLC53,024$15.6K0.00%
Flputnam Investment Management Co51,800$15.3K0.00%
Jane Street Group, LLC38,595$11.4K0.00%
Glassman Wealth Services34,779$10.2K0.00%
XTX Topco Ltd32,677$9.63K0.00%
BluePath Capital Management, LLC29,038$8.55K0.01%
Gerber Kawasaki Wealth & Investment Management15,440$4.55K0.00%
Newbridge Financial Services Group, Inc.2,000$5890.00%
FMR LLC86$250.00%
Qube Research & Technologies Ltd4$10.00%

Sold out (4)

Institutions that held PAVmed Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of PAVM in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Belpointe Asset Management LLC15,000$6.12K
Cetera Investment Advisers13,250$5.40K
Susquehanna International Group, LLP13,246$5.40K
CarsonAllaria Wealth Management, Ltd.1,100$449